
Lunsumio(Mosunetuzumab-axgb)

Rolvedon(Eflapegrastim-xnst)

Pemazyre(Pemigatinib)

DANYELZA

CELSENTRI(maraviroc)

ZYDELIG(idelalisib)

Rezlidhia(Olutasidenib)

Jaypirca(Pirtobrutinib)

Columvi(Glofitamab-gxbm)

Feraccru(Ferric Maltol)

Adakveo(Crizanlizumab-tmca)
![ANDEXXA® (coagulation factor Xa [recombinant], inactivated-zhzo) is a recombinant modified human factor Xa (FXa) protein indicated for patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding. Manufacturer: Portola Pharmaceuticals](images/Hematology/Andexxa.jpg)
Andexxa(Ondexxya)

Ninlaro(Ixazomib)

Cablivi(Caplacizumab-yhdp)

Rezurock(Belumosudil)

Empaveli(Pegcetacoplan)

Idhifa(Enasidenib)

Besponsa(Inotuzumab Ozogamicin)

Tibsovo(Ivosidenib)

Poteligeo(Mogamulizumab-kpkc)

Xospata(Gilteritinib)

Asparlas(Calaspargase Pegol-mknl)

Polivy(Polatuzumab Vedotin-piiqa)

Reblozyl(Luspatercept–aamt)

Zynlonta(Loncastuximab Tesirine-lpyl)

Rylaze

Scemblix®(Asciminib)

Besremi(Ropeginterferon Alfa-2b-njft)

Sarclisa®(Isatuximab-irfc)

Inqovi(Decitabine and Cedazuridine)

Monjuvi(Tafasitamab-cxix)

Mylotarg Gemtuzumab

Aliqopa(Copanlisib)

Brentuximab Vedotin

Agrylin(Anagrelide Hydrochloride)

Blincyto(Blinatumomab)

Erwinaze(Asparaginase Erwinia Chrysanthemi)

Folotyn(Pralatrexate)

Treosulfan(Treosulfan)

Ponatinib

Nplate(Romiplostim)

Mabcampath(Alemtuzumab)

Venclexta(Venetoclax)

Soliris(Eculizumab)

Alkeran(Melphalan)

Farydak(Panobinostat)

Bosulif(Bosutinib)

Eldisine(Vindesine Sulphate)

Tepadina(Thiotepa)

Zolinza(Vorinostat)